FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
5.75
+0.59 (11.43%)
At close: Jun 20, 2025, 4:00 PM
5.87
+0.12 (2.09%)
After-hours: Jun 20, 2025, 4:08 PM EDT
FibroGen Market Cap
FibroGen has a market cap or net worth of $23.24 million as of June 20, 2025. Its market cap has decreased by -81.01% in one year.
Market Cap
23.24M
Enterprise Value
79.76M
1-Year Change
-81.01%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $23.24M, a decrease of -98.10%. That is a compound annual growth rate of -31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 20.90M | -60.86% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.48B |
| Johnson & Johnson | 359.97B |
| Novo Nordisk | 333.14B |
| AbbVie | 326.86B |
| UnitedHealth Group | 276.84B |
| Abbott Laboratories | 231.07B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |